KURA
Kura Oncology, Inc.
Kura Oncology, Inc. (KURA) has 7 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 22, 2026.
Insiders have net sold $989K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Troy Wilson
- Employees:260
- HQ:San Diego, CA, US
- IPO:2015-09-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$989K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$849.6M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Leoni MollieFirst filing | Chief Medical Officer | Sale | 84,929 | $834K | Jun 22 | SEC ↗ |
| Chief Commercial Officer | Sale | 10,000 | $110K | May 22 | SEC ↗ | |
Bair Teresa BrophyFirst filing | Chief Legal Officer | Sale | 2,256 | $21K | May 20 | SEC ↗ |
FORD KATHLEENFirst filing | Chief Operating Officer | Sale | 2,257 | $20K | May 20 | SEC ↗ |
Powl Brian T.First filing | Chief Commercial Officer | Sale | 339 | $3K | May 20 | SEC ↗ |
Related companies
Kura Oncology, Inc. is in the Healthcare sector.